https://www.selleckchem.com/pr....oducts/Azacitidine(V
3%]) than in patients with paroxysmal AF (N = 275 [51.5%], P less then .001). Frequency of AES prior to PVI was not correlated with development (P = .203) or timing (P = .478) of AF recurrences. AF recurrences occurred both more frequently (P less then .001) and earlier (P less then .00 in patients with AF during the blanking period. Conclusion AES/day prior to PVI is not correlated with (timing of) AF during the blanking period or AF recurrences, and is therefore not a feasible marker for AF recurrences in patients with P
Like
Comment
Share
